Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State

Clinical trial NCT01002807 · COMPLETED

Trial details

NCT number

NCT01002807

Sponsor

AstraZeneca

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2009-11-01

Primary completion

2009-12-01

Enrollment

15

View on ClinicalTrials.gov